Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery

References

• Abdous B, Sajjadi S, Ma'mani L. 2017. β-Cyclodextrin modified mesoporous silica nanoparticles as a nano-carrier: Response surface methodology to investigate and optimize loading and release processes for curcumin delivery. J Appl Biomed. 15(3):210–218.
   Web of Science ®Google Scholar
• Al-Nadaf AH, Dahabiyeh LA, Bardaweel S, Mahmoud NN, Jawarneh S. 2020. Functionalized mesoporous silica nanoparticles by lactose and hydrophilic polymer as a hepatocellular carcinoma drug delivery system. J Drug Delivery Sci Technol. 56:101504.
   Web of Science ®Google Scholar
• Bouchoucha MC, Gaudreault R, Fortin MA, Kleitz F. 2014. Mesoporous silica nanoparticles: selective surface functionalization for optimal relaxometric and drug loading performances. Adv Funct Mater. 24(37):5911–5923.
   Web of Science ®Google Scholar
• Cabañas MV, Lozano D, Torres-Pardo A, Sobrino C, González-Calbet J, Arcos D, Vallet-Regí M. 2018. Features of aminopropyl modified mesoporous silica nanoparticles. Implications on the active targeting capability. Mater Chem Phys. 220 (2018):260–269.
   Google Scholar
• Caliceti P, Salmaso S, Semenzato A, Carofiglio T, Fornasier R, Fermeglia M, Ferrone M, Pricl S. 2003. Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery. Bioconjug Chem. 14(5):899–908.
   PubMed Web of Science ®Google Scholar
• Carparo EF, Maria LB, Giovanna P, Gennara C. 2011. Nanoparticulate systems for drug delivery and targetingto the central nervous system. Cns Neurosci Ther. 17:670–677.
   PubMed Web of Science ®Google Scholar
• Chang S, Hongdan L, Yijie S, Guan W, Liwei L, Liang Z, Rongjian S. 2014. Carboxymethyl-b-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid. Int J Pharm. 474 (2014):202–211.
   PubMedGoogle Scholar
• Erdem M, Yalcin S, Gunduz U. 2017. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: preparation, characterization and cytotoxicity on HeLa cell line. Hum Exp Toxicol. 36(8):833–845.
   PubMed Web of Science ®Google Scholar
• Farjadian F, Roointan A, Mohammadi-Samani S, Hosseini M. 2019. Mesoporous silica nanoparticles: synthesis, pharmaceutical applications, biodistribution, and biosafety assessment. Chem Eng J. 359:684–705.
   Web of Science ®Google Scholar
• Ghosh D, Choudhury ST, Ghosh S, Mandal AK, Sarkar S, Ghosh A, Saha KD, Das N. 2012. Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat. Chem Biol Interact. 195(3):206–214.
   PubMed Web of Science ®Google Scholar
• Graf C, Gao Q, Schütz I, Noufele CN, Ruan W, Posselt U, Korotianskiy E, Nordmeyer D, Rancan F, Hadam S, et al. 2012. Surface functionalization of silica nanoparticles supports colloidal stability in physiological media and facilitates internalization in cells. Langmuir. 28(20):7598–7613.
   PubMed Web of Science ®Google Scholar
• Hao N, Li L, Zhang Q, Huang X, Meng X, Zhang Y, Chen D, Tang F, Li L. 2012. The shape effect of PEGylated mesoporous silica nanoparticles on cellular uptake pathway in Hela cells. Micropor Mesopor Mat. 162:14–23.
   Web of Science ®Google Scholar
• He Q, Shi J. 2011. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem. 21(16):5845.
   Web of Science ®Google Scholar
• Injac R, Strukelj B. 2008. Recent advances in protection against doxorubicin-induced toxicity. Technol Cancer Res Treat. 7(6):497–516.
   PubMed Web of Science ®Google Scholar
• Kaasalainen M, Aseyev V, von Haartman E, Karaman DŞ, Mäkilä E, Tenhu H, Rosenholm J, Salonen J. 2017. Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering. Nanoscale Res Lett. 12(1):74.
   PubMed Web of Science ®Google Scholar
• Kao K-C, Lin T-S, Mou C-Y. 2014. Enhanced activity and stability of lysozyme by immobilization in the matching nanochannels of mesoporous silica nanoparticles. J Phys Chem C. 118(13):6734–6743.
   Web of Science ®Google Scholar
• Khosravian P, Shafiee Ardestani M, Khoobi M, Ostad SN, Dorkoosh FA, Akbari Javar H, Amanlou M. 2016. Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel. Onco Targets Ther. 9:7315–7330.
   PubMed Web of Science ®Google Scholar
• Krishnaiah YSR. 2010. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J Bioequiv Availab. 2:28–36.
   Google Scholar
• Leamon CP, Low PS. 1994. Selective targeting of malignant cells with cytotoxin-folate conjugates. J Drug Target. 2(2):101–112.
   PubMed Web of Science ®Google Scholar
• Mamaeva V, Rosenholm JM, Bate-Eya LT, Bergman L, Peuhu E, Duchanoy A, Fortelius LE, Landor S, Toivola DM, Linden M, et al. 2011. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. Mol Ther. 19(8):1538–1546.
   PubMed Web of Science ®Google Scholar
• Masood F. 2016. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C Mater Biol Appl. 60:569–578.
   PubMed Web of Science ®Google Scholar
• Mehmood A, Ghafar H, Yaqoob S, Gohar UF, Ahmad B. 2017. Mesoporous silica nanoparticles: a review. J Develop Drugs. 6:2.
   Google Scholar
• Mu Q, Hondow N, Krzemińsk Ł, Brown A, Jeuken L, Routledge MN. 2012. Mechanism of cellular uptake of genotoxic silica nanoparticles. Part Fibre Toxicol. 9:29.
   PubMed Web of Science ®Google Scholar
• Nadda M, Tullayakorn P, Kesara N. 2018. Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int J Nanomedicine. 13:3921–3935.
   PubMed Web of Science ®Google Scholar
• Nanjing H., Linlin L., Qiang Z., Xinglu H., Xianwei M., Yanqi Z., Dong C., Fangqiong T., Laifeng L,.2012. The shape effect of PEGylated mesoporous silica nanoparticles on cellular uptake pathway in HeLa cells. Micropor Mesopor Mat. 162:14–23.
   Google Scholar
• Ocal H, Arica-Yegin B, Vural I, Goracinova K, Caliş S. 2014. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies. Drug Dev Ind Pharm. 40(4):560–567.
   PubMed Web of Science ®Google Scholar
• Pada AK, Desai D, Sun K, Prakirth Govardhanam N, Törnquist K, Zhang J, Rosenholm JM. 2019. Comparison of polydopamine-coated mesoporous silica nanorods and spheres for the delivery of hydrophilic and hydrophobic anticancer drugs. IJMS. 20(14):3408.
   Google Scholar
• Park S, Hyungkyu P, Seokhyeon J, Bong GY, Kyeongsoon P, Jaehong K. 2019. Hyaluronic acid-conjugated mesoporous silica nanoparticles loaded with dual anticancer agents for chemophotodynamic cancer therapy. J. Nanomater. 2019:1–11.
   Web of Science ®Google Scholar
• Peracchia MT. 2003. Stealth nanoparticles for intravenous administration. STP Pharma Sci. 13:155–161.
   Google Scholar
• Quan Z, Koon GN, Liqun X, Shengjie L, En T, Ratha M, Edmund C. 2014. Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy. Langmuir. 30:6151–6161.
   PubMed Web of Science ®Google Scholar
• Samar HT, Imad IH, Dina E, Afaf HA. 2016. Effect of loratadine on the dissolution and bioavailability of gliclazide from its hydroxypropyl-b-cyclodextrin complex. J Incl Phenom Macrocycl Chem.  85, 203–216.
   Web of Science ®Google Scholar
• Tacar O, Sriamornsak P, Dass CR. 2013. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 65(2):157–170.
   PubMed Web of Science ®Google Scholar
• Tenland E, Pochert A, Krishnan N, Umashankar Rao K, Kalsum S, Braun K, Glegola-Madejska I, Lerm M, Robertson BD, Lindén M, et al. 2019. Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles. PLoS One. 14(2):e0212858.
   PubMed Web of Science ®Google Scholar
• Thapa P, Mengjie L, Radha K, Moses B, Pallavi R, Gregory N, Sukyung W, Youngjae Y. 2017. Folate-PEG conjugates of a far-red light-activatable paclitaxel prodrug to improve selectivity toward folate receptor-positive cancer cells. ACS Omega. 2(10):6349–6360.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huameng G, Wanxia W, Honghao S, Mingxing L. 2016. Synthesis and characterization of amino-terminated polyethylene glycol functionalized mesoporous silica nanoparticles. 5th International Conference on Measurement, Instrumentation and Automation (ICMIA 2016), 80–84.
   Google Scholar
• Xu C, Lei C, Yu C. 2019. Mesoporous silica nanoparticles for protein protection and delivery. Front Chem. 7:article 290,1–12.
   Web of Science ®Google Scholar
• Xue WJ, Feng Y, Wang F. 2016. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma. Sci Rep. 26:22149.
   Google Scholar
• Zhang J, Rana S, Srivastava RS, Misra RDK. 2008. On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles. Acta Biomater. 4(1):40–48.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu J. 2018. Mesoporous silica nanoparticle-based intelligent drug delivery system for bienzyme-responsive tumour targeting and controlled release. R Soc Open Sci. 5(1):170986.
   PubMed Web of Science ®Google Scholar